|
GB9203689D0
(en)
*
|
1992-02-20 |
1992-04-08 |
Euro Celtique Sa |
Pharmaceutical composition
|
|
GB9310030D0
(en)
*
|
1993-05-15 |
1993-06-30 |
Scras |
Dry processed particles and process for the preparation of the same
|
|
GB9505032D0
(en)
*
|
1995-03-13 |
1995-05-03 |
Westminster Lab Ltd |
Improvements in or relating to organic compositions
|
|
GB9422154D0
(en)
|
1994-11-03 |
1994-12-21 |
Euro Celtique Sa |
Pharmaceutical compositions and method of producing the same
|
|
US5965161A
(en)
|
1994-11-04 |
1999-10-12 |
Euro-Celtique, S.A. |
Extruded multi-particulates
|
|
AU709301B2
(en)
*
|
1995-11-02 |
1999-08-26 |
Merck Frosst Canada & Co. |
New technology for wet granulation
|
|
JP2001505899A
(ja)
*
|
1996-12-12 |
2001-05-08 |
デーデーエス ドラッグ デリバリー サービス ゲセルシャフト ツーア フェアデルング デア フォルシュング イン ファーマシューティッシャー テクノロジー ウント バイオファーマジー エムベーハー |
任意に活性物質を含むマトリクス材料−賦形剤コンパウンドの形態の処方物
|
|
US5980882A
(en)
*
|
1997-04-16 |
1999-11-09 |
Medeva Pharmaceuticals Manufacturing |
Drug-resin complexes stabilized by chelating agents
|
|
US20060141036A1
(en)
*
|
1997-12-12 |
2006-06-29 |
Andrx Labs Llc |
HMG-CoA reductase inhibitor extended release formulation
|
|
US20040029962A1
(en)
*
|
1997-12-12 |
2004-02-12 |
Chih-Ming Chen |
HMG-COA reductase inhibitor extended release formulation
|
|
US5916595A
(en)
*
|
1997-12-12 |
1999-06-29 |
Andrx Pharmaceutials, Inc. |
HMG co-reductase inhibitor
|
|
IT1298574B1
(it)
*
|
1998-02-06 |
2000-01-12 |
Vectorpharma Int |
Composizioni farmaceutiche in forma di microparticelle a base polimerica ottenute mediante estrusione e sferonizzazione
|
|
US7122207B2
(en)
*
|
1998-05-22 |
2006-10-17 |
Bristol-Myers Squibb Company |
High drug load acid labile pharmaceutical composition
|
|
UA69413C2
(uk)
|
1998-05-22 |
2004-09-15 |
Брістол-Майерс Сквібб Компані |
Фармацевтична композиція, яка містить серцевину та ентеросолюбільну оболонку, фармацевтична композиція у вигляді сфероїдальних гранул, спосіб одержання сфероїдальних гранул та спосіб одержання фармацевтичної композиції
|
|
UA73092C2
(uk)
|
1998-07-17 |
2005-06-15 |
Брістол-Майерс Сквібб Компані |
Таблетка з ентеросолюбільним покриттям і спосіб її приготування
|
|
DE19855440A1
(de)
*
|
1998-12-01 |
2000-06-08 |
Basf Ag |
Verfahren zum Herstellen fester Darreichungsformen mittels Schmelzextrusion
|
|
DE19918325A1
(de)
|
1999-04-22 |
2000-10-26 |
Euro Celtique Sa |
Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
|
|
CA2379987A1
(en)
*
|
1999-07-29 |
2001-02-08 |
Roxane Laboratories, Inc. |
Opioid sustained-released formulation
|
|
US6764694B1
(en)
*
|
1999-08-31 |
2004-07-20 |
Mutual Pharmaceutical Co., Inc. |
Stable formulations of ACE inhibitors, and methods for preparation thereof
|
|
US20040157911A1
(en)
*
|
1999-08-31 |
2004-08-12 |
Spiridon Spireas |
Storage-stable and bio-stable formulations of ace inhibitors, and methods for preparation thereof
|
|
US20030225124A1
(en)
*
|
1999-08-31 |
2003-12-04 |
Spiridon Spireas |
Stable formulations of ACE inhibitors, and methods for preparation thereof
|
|
US6555551B1
(en)
|
1999-08-31 |
2003-04-29 |
Mutual Pharmaceutical Co., Inc. |
Stable formulations of ACE inhibitors, and methods for preparation thereof
|
|
DE10008506A1
(de)
*
|
2000-02-24 |
2001-09-13 |
Bayer Ag |
Verfahren zur Herstellung von pharmazeutischen Darreichungsformen
|
|
EP2382970B1
(en)
*
|
2000-04-10 |
2013-01-09 |
Teva Pharmaceutical Industries, Ltd. |
Stable Pharmaceutical Compositions Containing 7-Substituted-3,5-Dihydroxyheptanoic Acids or 7-Substituted-3,5-Dihydroxyheptenoic Acids
|
|
USRE44578E1
(en)
|
2000-04-10 |
2013-11-05 |
Teva Pharmaceutical Industries, Ltd. |
Stable pharmaceutical compositions containing 7-substituted-3,5-dihydroxyheptanoic acids or 7-substituted-3,5-dihydroxyheptenoic acids
|
|
EP1679962B1
(en)
*
|
2003-10-20 |
2021-01-13 |
Framework Therapeutics, L.L.C. |
Zeolite molecular sieves for the removal of toxins
|
|
US7387793B2
(en)
|
2003-11-14 |
2008-06-17 |
Eurand, Inc. |
Modified release dosage forms of skeletal muscle relaxants
|
|
DE102005042875A1
(de)
*
|
2004-12-23 |
2006-09-21 |
Grünenthal GmbH |
Schnell freisetzende Darreichungsformen für Antibiotika
|
|
US8318230B2
(en)
*
|
2005-05-02 |
2012-11-27 |
Henkel Ag & Co. Kgaa |
Use of debranched starch in extrusion-spheronization pharmaceutical pellets
|
|
US7884136B2
(en)
|
2005-06-27 |
2011-02-08 |
Biovail Laboratories International S.R.L. |
Modified-release formulations of a bupropion salt
|
|
US20090246276A1
(en)
|
2008-01-28 |
2009-10-01 |
Graham Jackson |
Pharmaceutical Compositions
|
|
RU2011112694A
(ru)
*
|
2008-09-02 |
2012-10-10 |
Юсв Лимитед (In) |
Сшитые полимеры
|
|
WO2012042314A1
(en)
|
2010-10-02 |
2012-04-05 |
Link Research & Grants Corporation |
Treatment of tinnitus and related auditory dysfunctions
|
|
SMT201800453T1
(it)
|
2010-11-04 |
2018-11-09 |
Albireo Ab |
Inibitori di ibat per il trattamento delle epatopatie
|
|
US20120308895A1
(en)
|
2011-05-31 |
2012-12-06 |
General Electric Company |
Electrode compositions useful for energy storage devices and other applications; and related devices and processes
|
|
JP6751020B2
(ja)
|
2014-06-25 |
2020-09-02 |
Ｅａファーマ株式会社 |
固形製剤及びその着色防止又は着色低減方法
|
|
EP3012252A1
(en)
|
2014-10-24 |
2016-04-27 |
Ferring BV |
Crystal modifications of elobixibat
|
|
CN108601739B
(zh)
*
|
2016-02-09 |
2022-01-04 |
阿尔比里奥公司 |
考来烯胺丸剂及其制备方法
|
|
US10441605B2
(en)
|
2016-02-09 |
2019-10-15 |
Albireo Ab |
Oral cholestyramine formulation and use thereof
|
|
US10786529B2
(en)
|
2016-02-09 |
2020-09-29 |
Albireo Ab |
Oral cholestyramine formulation and use thereof
|
|
US10441604B2
(en)
|
2016-02-09 |
2019-10-15 |
Albireo Ab |
Cholestyramine pellets and methods for preparation thereof
|
|
CA3071285A1
(en)
|
2017-08-09 |
2019-02-14 |
Albireo Ab |
Cholestyramine granules, oral cholestyramine formulations and use thereof
|
|
CA3071182A1
(en)
*
|
2017-08-09 |
2019-02-14 |
Albireo Ab |
Cholestyramine pellets, oral cholestyramine formulations and use thereof
|
|
CN107552777A
(zh)
*
|
2017-09-05 |
2018-01-09 |
昆山玛冀电子有限公司 |
一种用于电感生产的粉末颗粒成分及生产工艺
|
|
WO2019087084A1
(en)
|
2017-11-02 |
2019-05-09 |
Eman Biodiscoveries Sd. Bhd. |
Extract of orthosiphon stamineus, formulations, and uses thereof
|
|
US10793534B2
(en)
|
2018-06-05 |
2020-10-06 |
Albireo Ab |
Benzothia(di)azepine compounds and their use as bile acid modulators
|
|
TW202015699A
(zh)
|
2018-06-05 |
2020-05-01 |
瑞典商艾爾比瑞歐公司 |
苯并噻(二)氮呯(benzothia(di)azepine)化合物及其作為膽汁酸調節劑之用途
|
|
US11801226B2
(en)
|
2018-06-20 |
2023-10-31 |
Albireo Ab |
Pharmaceutical formulation of odevixibat
|
|
FI3810581T3
(fi)
|
2018-06-20 |
2025-02-28 |
Albireo Ab |
Odeviksibaatin kiteiset modifikaatiot
|
|
US11549878B2
(en)
|
2018-08-09 |
2023-01-10 |
Albireo Ab |
In vitro method for determining the adsorbing capacity of an insoluble adsorbant
|
|
US10722457B2
(en)
|
2018-08-09 |
2020-07-28 |
Albireo Ab |
Oral cholestyramine formulation and use thereof
|
|
US11007142B2
(en)
|
2018-08-09 |
2021-05-18 |
Albireo Ab |
Oral cholestyramine formulation and use thereof
|
|
US10941127B2
(en)
|
2019-02-06 |
2021-03-09 |
Albireo Ab |
Benzothiadiazepine compounds and their use as bile acid modulators
|
|
ES2937153T3
(es)
|
2019-02-06 |
2023-03-24 |
Albireo Ab |
Compuestos de benzotiadiazepinas y su uso como moduladores de ácidos biliares
|
|
US10975045B2
(en)
|
2019-02-06 |
2021-04-13 |
Aibireo AB |
Benzothiazepine compounds and their use as bile acid modulators
|
|
CN114761018B
(zh)
|
2019-12-04 |
2025-12-02 |
阿尔比里奥公司 |
苯并硫杂二氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途
|
|
ES2973355T3
(es)
|
2019-12-04 |
2024-06-19 |
Albireo Ab |
Compuestos de benzotia(di)azepina y su uso como moduladores del ácido biliar
|
|
US11014898B1
(en)
|
2020-12-04 |
2021-05-25 |
Albireo Ab |
Benzothiazepine compounds and their use as bile acid modulators
|
|
CA3158276A1
(en)
|
2019-12-04 |
2021-06-10 |
Per-Goran Gillberg |
Benzothia(di)azepine compounds and their use as bile acid modulators
|
|
KR20220109450A
(ko)
|
2019-12-04 |
2022-08-04 |
알비레오 에이비 |
벤조티아(디)아제핀 화합물 및 담즙산 조절제로서의 이의 용도
|
|
CA3186857A1
(en)
|
2020-08-03 |
2022-02-10 |
Per-Goran Gillberg |
Benzothia(di)azepine compounds and their use as bile acid modulators
|
|
JP2023549226A
(ja)
|
2020-11-12 |
2023-11-22 |
アルビレオ エービー |
進行性家族性肝内胆汁うっ滞症（ｐｆｉｃ）を処置するためのオデビキシバット
|
|
CN116583504A
(zh)
|
2020-12-04 |
2023-08-11 |
阿尔比里奥公司 |
苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途
|
|
TW202313579A
(zh)
|
2021-06-03 |
2023-04-01 |
瑞典商艾爾比瑞歐公司 |
苯并噻(二)氮呯(benzothia(di)azepine)化合物及其作為膽酸調節劑之用途
|